Rest and PH: When My Body Talks, I Listen - Pulmonary Hypertension News

Rest and PH: When My Body Talks, I Listen - Pulmonary Hypertension News

Rest and PH: When My Body Talks, I Listen - Pulmonary Hypertension News

Posted: 30 Sep 2019 01:00 PM PDT

When a person is diagnosed with a serious condition like pulmonary hypertension (PH), they must alter their lifestyle. One of my biggest challenges has been learning to take it easy.

I like to keep busy, and I tend to get a bit glum if I lie in bed all day or don't leave the house. But when living with a chronic illness, I must accept that if I say yes to everything and don't give myself time to rest, I'll probably get sick. I've learned this lesson the hard way!

I have tried many times to keep up with friends, only to have to take time off work to recover. Fear of missing out can lead to some unwise decisions. That said, it's all about balance — I can't drink green juices and go to bed at 9 p.m. every day. I must have some fun!

It sounds like a cliché, but it's true: I must listen to my body. My shortness of breath directly correlates with how much sleep I get, so I must be strict about getting a full eight hours. People with chronic illnesses need more sleep than healthy people do, but ironically, PH makes sleeping difficult. I could — and plan to — write a column about the sleep habits that help me manage my symptoms.

One way to strike a balance between rest and fun is to plan ahead. If I'll be doing something exciting on Saturday, I try to keep Sunday free to rest up. However, I can't predict how I'm going to feel on any given day. Some days, I wake up with zero energy, even if I've had a nice, long sleep. So, I must be flexible, and I always try to seize the day when I'm feeling good.

The shift between good and bad days can be difficult for friends to understand. They might see me dancing around, relatively symptom-free on one day and assume I must always be like that. I have learned to better communicate my needs, and now I often ask friends to come round and watch a movie instead of going out.

I still overdo it sometimes, but I'm learning. The online chronic illness community reminds me not to be disappointed in myself if I don't have the energy for something, and to always be kind to my body.

***

Note: Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Pulmonary Hypertension News or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to pulmonary hypertension.

×

Comments

Post a Comment

Popular posts from this blog

Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor

Image
Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Posted: 11 Jul 2019 12:00 AM PDT For patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction, inhaled epoprostenol through high-flow nasal cannula increases oxygenation, according to a study published in Pharmaceutics . The researchers of this retrospective study assessed the effect of inhaled epoprostenol using a high-flow nasal cannula on oxygenation and future mechanical ventilation in patients with hypoxemia comorbid with pulmonary hypertension or right heart dysfunction in an intensive care unit setting. A chart review was completed on adult patients who were admitted into the respiratory care department of the Rush University Medical Center for severe hypoxemia between July 2015 and April 2018 and treated with inha...
Read more

Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News

Image
Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News Growing Doubt, Uncertainty Over PDE5i Use in Left Heart Disease - Medscape AnMed Health gains national recognition through the Pulmonary Hypertension Association - WSPA.com Novitium's Generic Sildenafil for PAH Treatment Approved by FDA - Pulmonary Hypertension News Posted: 12 Jun 2019 05:00 AM PDT The U.S. Food and Drug Administration (FDA) has approved Novitium Pharma 's generic sildenafil for oral suspension at a dose of 10 mg/mL for the treatment of pulmonary arterial hypertension (PAH). This product, which had been designated a competitive generic therapy by the FDA, is the first approved generic equivalent to Pfizer 's Revatio , a vasodilator agent that induces blood ves...
Read more

Analysis: Large pharma companies do little new drug innovation - STAT

Image
Analysis: Large pharma companies do little new drug innovation - STAT Analysis: Large pharma companies do little new drug innovation - STAT Gene Therapy Takes Center Stage at 2019 NORD Summit - Pulmonary Hypertension News People Living With Type 2 Diabetes Want Information and Empathy From Their Doctors More Than New Medications - PRNewswire Analysis: Large pharma companies do little new drug innovation - STAT Posted: 10 Dec 2019 01:51 AM PST L arge pharmaceutical companies oppose legislation being considered by Congress to lower the prices of prescription drugs. Reducing their revenues, they contend, will reduce their investment in drug development and the discovery of new medicines, and thus lead to a decline in drug innovation. If that argument is credible, there should be evidence to show that the large pharmaceutical companies are responsible for discovering innovative new drugs. To test that claim, we examined the...
Read more